Literature DB >> 18197432

Central venous catheter-related thrombosis in cancer patients: what we know and what we need to know.

Davide Tassinari, Carlotta Santelmo, Paola Tombesi, Sergio Sartori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18197432     DOI： 10.1007/s00520-007-0385-x

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  16 in total

Review 1.  Prevention of venous thromboembolism.

Authors:  W H Geerts; J A Heit; G P Clagett; G F Pineo; C W Colwell; F A Anderson; H B Wheeler
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

2.  Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): is prophylaxis required?

Authors:  L Orlando; M Colleoni; F Nolè; R Biffi; A Rocca; G Curigliano; G Ferretti; G Peruzzotti; F de Braud; G Masci; A Goldhirsch
Journal:  Ann Oncol       Date:  2000-01       Impact factor: 32.976

Review 3.  Aspirin in the prevention and treatment of venous thromboembolism.

Authors:  M M C Hovens; J D Snoep; J T Tamsma; M V Huisman
Journal:  J Thromb Haemost       Date:  2006-07       Impact factor: 5.824

4.  Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients.

Authors:  Melina Verso; Giancarlo Agnelli; Sergio Bertoglio; Franco C Di Somma; Francesco Paoletti; Walter Ageno; Mario Bazzan; Pasquale Parise; Roberto Quintavalla; Emanuele Naglieri; Armando Santoro; Davide Imberti; Mariella Sorarù; Stefano Mosca
Journal:  J Clin Oncol       Date:  2005-03-14       Impact factor: 44.544

5.  Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer.

Authors:  Stephen Couban; Michael Goodyear; Margot Burnell; Sean Dolan; Parveen Wasi; David Barnes; Darlene Macleod; Erica Burton; Pantelis Andreou; David R Anderson
Journal:  J Clin Oncol       Date:  2005-03-14       Impact factor: 44.544

6.  Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials.

Authors:  A G Randolph; D J Cook; C A Gonzales; M Andrew
Journal:  Chest       Date:  1998-01       Impact factor: 9.410

7.  Low-dose aspirin for the prevention of venous thromboembolism in breast cancer patients treated with infusional chemotherapy after insertion of central vein catheter.

Authors:  Giuseppe Curigliano; Alessandra Balduzzi; Anna Cardillo; Raffaella Ghisini; Giulia Peruzzotti; Laura Orlando; Rosalba Torrisi; Silvia Dellapasqua; Loredana Lunghi; Aron Goldhirsch; Marco Colleoni
Journal:  Support Care Cancer       Date:  2007-06-20       Impact factor: 3.603

Review 8.  Venous thromboembolism associated with long-term use of central venous catheters in cancer patients.

Authors:  Melina Verso; Giancarlo Agnelli
Journal:  J Clin Oncol       Date:  2003-10-01       Impact factor: 44.544

Review 9.  Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review.

Authors:  Clara P W Klerk; Susanne M Smorenburg; Harry R Büller
Journal:  Arch Intern Med       Date:  2003-09-08

10.  Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial.

Authors:  Patrick Mismetti; Dominique Mille; Silvy Laporte; Véronique Charlet; Andréa Buchmüller-Cordier; Jean-Philippe Jacquin; Pierre Fournel; Claire Dutrey-Dupagne; Herv Decousus
Journal:  Haematologica       Date:  2003-01       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.